Intramedullary nails are structural implants used in orthopedic surgeries for treatment of bone fractures and other orthopedic disorders. Intramedullary nails provide stabilization and alignment to fractured long bones. They offer benefits such as less soft tissue dissection, greater stability, and early mobilization as compared to traditional plating techniques. The global Intramedullary Nail Market is estimated to be valued at US$ 1.95 Billion in 2023 and is expected to exhibit a CAGR of 8.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

The increased usage of intramedullary nails in trauma surgeries is driving the market growth. Intramedullary nails are widely used for stabilization of fractures of long bones like femur, tibia and humerus caused by high-energy trauma such as road accidents. According to World Health Organization (WHO), road traffic injuries cause around 1.35 million deaths globally each year. Moreover, rise in sports injuries and geriatric population prone to osteoporotic fractures is also fueling the demand for intramedullary nails. Introduction of new intramedullary nail systems integrated with distal targeting/interlocking capabilities and improved fixation technology is further augmenting the market growth.
Segment Analysis

The global intramedullary nail market is dominated by the femur nail sub-segment. Femur fractures are among the most common reasons for musculoskeletal trauma globally, especially among the elderly population. Femur nails act as an internal splint that aids in stabilize femur fractures and enables early mobilization, thereby significantly reducing recovery timelines.

Key Takeaways

The  Global Intramedullary Nail Market Size is expected to witness high growth over the forecast period of 2023 to 2030. Advancements in locking nail technologies, the increasing demand for minimally invasive surgeries and rising popularity of ambulatory surgical centers and specialty orthopedic clinics are expected to drive the market during this period.

Regional analysis

North America currently dominates the intramedullary nail market owing to growth in trauma cases, rising healthcare expenditure and presence of major players in the region. However, the Asia Pacific region is poised to witness the highest CAGR during the forecast period supported by growing orthopedic interventions, increasing healthcare spending and expanding medical infrastructure in countries such as China and India.

Key players operating in the intramedullary nail market are Zimmer Biomet, Smith & Nephew, Stryker, DePuy Synthes, Orthofix, Bioventus LLC, and Medtronic. Zimmer Biomet dominates the market with their extensive product portfolio and global presence. Meanwhile, Stryker is focused on launching innovative nails to strengthen its market position.

Get More Insights On This Topic: https://www.pressreleasebulletin.com/intramedullary-nail-market-overview/